Ender S A, Gradl G, Ender M, Langner S, Merk H R, Kayser R
Department of Orthopaedics and Orthopaedic Surgery, University Medicine Greifswald.
Department of Trauma, Hand and Reconstructive Surgery, University Medicine Rostock.
Rofo. 2014 Apr;186(4):380-7. doi: 10.1055/s-0033-1355504. Epub 2013 Oct 18.
Determining whether implantation of an expandable titanium mesh cage (Osseofix® system) is a successful and safe minimally invasive therapy for osteoporotic and tumorous vertebral compression fractures (VCFs).
32 patients (25 women, 7 men, mean age 71) with 46 osteoporotic or tumorous VCFs (T6 to L4) from June 2010 to January 2012 were included. All of them were stabilized with the Osseofix® system. Preinterventionally we performed X-ray, MRI, and bone density measurements (DXA). The clinical and radiological results were evaluated preop, postop and 12 months postop based on the visual analog scale (VAS) and the Oswestry Disability Index (ODI), X-ray (Beck Index, Cobb angle) and CT.
There was a significant improvement in pain intensity (VAS) (7.8 to 1.6) as well as a significant reduction in the mean ODI (71.36 % to 30.4 %) after 12 months. The mean kyphotic angle according to Cobb showed significant improvements (12.3° to 10.8°) after 12 months. Postinterventional imaging showed one case of loss of height in a stabilized lumbar vertebral body (2.2 %) in osteoporosis and one case with adjacent fracture (2.2 %) in osteoporosis. We saw no changes in the posterior vertebral wall. Except for one pronounced postoperative hematoma, we saw no surgical complications including no cement leakage.
The clinical mid-term results are good at a low complication rate. The stabilization of symptomatic osteoporotic and tumorous VCFs with the Osseofix® system is a safe and effective procedure, even in fractures with posterior wall involvement. The Osseofix® system is an interesting alternative to the established procedures of cement augmentation.
• The Osseofix® system is well suited for stabilizing osteoporotic and tumorous VCFs.• It is a safe and effective procedure without cement leakage and with a low complication rate.• The procedure is an interesting alternative to established cement augmentation procedures.
确定植入可扩张钛网笼(Osseofix®系统)对于骨质疏松性和肿瘤性椎体压缩骨折(VCF)是否是一种成功且安全的微创治疗方法。
纳入2010年6月至2012年1月期间32例患者(25例女性,7例男性,平均年龄71岁),共46处骨质疏松性或肿瘤性VCF(T6至L4)。所有患者均采用Osseofix®系统进行固定。干预前,我们进行了X线、MRI和骨密度测量(DXA)。基于视觉模拟量表(VAS)和Oswestry功能障碍指数(ODI)、X线(贝克指数、Cobb角)和CT,在术前、术后及术后12个月对临床和影像学结果进行评估。
12个月后,疼痛强度(VAS)有显著改善(从7.8降至1.6),平均ODI也显著降低(从71.36%降至30.4%)。根据Cobb测量的平均后凸角在12个月后有显著改善(从12.3°降至10.8°)。介入后影像学检查显示,骨质疏松患者中有1例稳定的腰椎椎体高度丢失(2.2%),骨质疏松患者中有1例发生相邻骨折(2.2%)。我们未观察到椎体后壁有变化。除1例明显的术后血肿外,未观察到手术并发症,包括无骨水泥渗漏。
临床中期结果良好,并发症发生率低。使用Osseofix®系统稳定有症状的骨质疏松性和肿瘤性VCF是一种安全有效的方法,即使是累及后壁的骨折。Osseofix®系统是已确立的骨水泥强化手术的一种有吸引力的替代方法。
• Osseofix®系统非常适合稳定骨质疏松性和肿瘤性VCF。• 这是一种安全有效的方法,无骨水泥渗漏,并发症发生率低。• 该手术是已确立的骨水泥强化手术的一种有吸引力的替代方法。